Insider trades
Julia G. Butchko, Chief Officer of Immunovant IMVT, has filed 0 purchases and 21 sales on the open market. The latest trade was on 24/08/21.
Julia G. Butchko
Chief Development Officer
- Company
- Immunovant IMVT
- First filing
- 23/01/13
- Trades
- 25 trades
- Buys / sales
- 0 / 21
- 12-month net buying
- No record
- Last trade
- 24/08/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 24/08/21 | 24/08/23 | 3,027 sh2 trades | $31.86avg. | $96,437.28 | −0.7% | |
| Open-market sale | 24/07/17 | 24/07/19 | 2,867 sh2 trades | $29.69avg. | $85,131.67 | −0.6% | |
ImmunovantIMVT | Open-market sale | 24/07/09 | 24/07/10 | 1,527 sh | $28.06 | $42,847.62 | −0.3% |
ImmunovantIMVT | Open-market sale | 24/05/22 | 24/05/24 | 3,247 sh | $29.65 | $96,273.55 | −0.7% |
| Open-market sale | 24/04/17 | 24/04/19 | 10,115 sh2 trades | $29.06avg. | $293,922.6 | −2.2% | |
ImmunovantIMVT | Open-market sale | 24/04/09 | 24/04/10 | 1,053 sh | $31.18 | $32,832.54 | −0.2% |
ImmunovantIMVT | Open-market sale | 24/02/22 | 24/02/23 | 2,146 sh | $36.15 | $77,577.9 | −0.5% |
ImmunovantIMVT | Open-market sale | 24/01/05 | 24/01/09 | 1,297 sh | $38.59 | $50,051.23 | −0.3% |
| Open-market sale | 23/11/22 | 23/11/24 | 3,265 sh2 trades | $32.78avg. | $107,024.23 | −0.8% | |
| Open-market sale | 23/10/05 | 23/10/06 | 1,735 sh2 trades | $36.24avg. | $62,885.05 | −0.4% | |
| Open-market sale | 23/08/24 | 23/08/25 | 12,333 sh2 trades | $20.30avg. | $250,360.49 | −2.9% | |
ImmunovantIMVT | Open-market sale | 23/07/12 | 23/07/13 | 1,470 sh | $19.73 | $29,003.1 | −0.3% |
ImmunovantIMVT | Open-market sale | 23/04/18 | 23/04/19 | 1,544 sh | $15.27 | $23,576.88 | −0.4% |
| Open-market sale | 23/01/11 | 23/01/13 | 60,490 sh2 trades | $16.79avg. | $1,015,596.13 | −15.4% |